Rani Therapeutics Holdings (RANI) FCF Margin (2020 - 2026)
Rani Therapeutics Holdings' (RANI) quarterly FCF Margin came in at 381.26% in Q1 2026, up 438618.0% year-on-year from N/an in Q1 2025, and down 2047.65% quarter-over-quarter from 19.58% in Q4 2025.
Rani Therapeutics Holdings (RANI) FCF Margin (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' FCF Margin history runs 5 years deep, the most recent figure standing at 381.26% for Q1 2026.
- On a quarterly basis, FCF Margin rose 438618.0% year-over-year to 381.26% in Q1 2026; TTM through Mar 2026 was 540.04%, a 233862.0% increase from a year earlier, with the FY2025 full-year figure at 1151.38%, up 232761.0% from the prior year.
- FCF Margin eased to 381.26% in Q1 2026 per RANI's latest filing, from 19.58% in the prior quarter.
- Across five years, FCF Margin topped out at 19.58% in Q4 2025 and bottomed at 4767.44% in Q1 2025.
- The 3-year median for FCF Margin is 613.1% (2024), against an average of 1493.52%.
- Across the five-year window, FCF Margin soared 86452 bps in 2025 and surged 438618 bps in 2026, its largest moves.
- Year by year, FCF Margin stood at 844.94% in 2024, then surged by 102 bps to 19.58% in 2025, then slumped by 2048 bps to 381.26% in 2026.
- Per Business Quant, the three latest RANI FCF Margin figures stand at 381.26% (Q1 2026), 19.58% (Q4 2025), and 4767.44% (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - | -381.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -381.26% |
| Dec 31, 2025 | 19.58% |
| Mar 31, 2025 | -4,767.44% |
| Dec 31, 2024 | -844.94% |
| Jun 30, 2021 | -296.02% |
| Mar 31, 2021 | -543.12% |
| Dec 31, 2020 | -3,570.48% |
| Sep 30, 2020 | 1,122.22% |